#USA #San Francisco #Therna Biosciences #RNA-Logix #Chronos Data

Therna Biosciences Unveils the Power of Chronos for RNA Research

In a groundbreaking announcement, Therna Biosciences has introduced Chronos, a transformative data engine that significantly enhances the capabilities of its AI RNA Biologist, RNA-Logix™. This innovative platform promises to revolutionize the understanding of RNA dynamics, vital for advancing therapeutic solutions.

Traditionally, biological research has relied on limited methodologies, often focusing on single RNA measurements in isolated cell types. In contrast, Chronos empowers researchers by generating extensive levels of functional RNA data in just one experiment. By utilizing this novel system, scientists can analyze tens of thousands of synthetic genes and messenger RNAs (mRNAs) across multiple human cell lines, resulting in millions of functional RNA measurements that reflect the complexities of biological systems.

Unlocking the Complexity of RNA Dynamics

Therna's Chronos leverages a proprietary method to deliver dynamic measurement capabilities that were previously unattainable. As a result, researchers now have access to a representative data set that has the potential to redefine molecular biology. The initial release includes data generated from Chronos Penta-47x27K and Tria-47x28K, showcasing its ability to track various RNA sequences over time within diverse cellular environments.

Dr. Nazli Azimi, CEO of Therna, remarked, “The foundation of RNA-Logix™ is built on the understanding that RNA is a language. By mastering this language, we can design novel medicines. The launch of Chronos signifies a major step toward producing a wealth of biological data essential for effective drug design.”

A Leap Forward in Data Generation

Conventional approaches to RNA measurement typically focus on individual mRNA strands at a singular moment in specific cell types. In stark contrast, Chronos takes a holistic view by simultaneously assessing thousands of mRNAs within a collective of 50 human cell lines. This comprehensive method not only captures expression changes over time but also allows researchers to explore how RNA sequences behave across different cellular contexts.

Therna has managed to accelerate the data collection process significantly, achieving approximately a 200x speedup through the use of rapids-single cell, an open-source package tailored for data science applications based on NVIDIA's CUDA-X platform. This advancement not only enhances data collection efficiency but also ensures that complex RNA interactions within live cells can be analyzed meaningfully.

Implications for Future Research

According to Dr. Hani Goodarzi, Scientific Co-Founder of Therna and faculty member at the University of California, San Francisco, “With Chronos, we can investigate what multiple RNA sequences do across multiple cellular environments simultaneously. The variability unveiled reveals how a sequence and the cells interpreting it interplay to influence biological behavior.” This understanding is critical in developing effective therapeutic strategies and drug designs.

Therna's release of its Chronos data set aims to foster collaboration with researchers and organizations interested in applying this cutting-edge technology. The company encourages potential partners to utilize this data for benchmarking, training sequence models, and further investigating RNA dynamics.

Conclusion: A New Frontier in Biotechnology

As Therna Biosciences launches Chronos, it sets the stage for a new frontier in RNA research, facilitating significant advancements in the design of RNA-based therapeutics. By releasing unprecedented data sets, Therna opens doors for collaborative research opportunities, inviting inquiry into the intricate language of RNA and how it can be harnessed for medical breakthroughs. Those eager to delve into the possibilities offered by Chronos can access the data set on platforms like Hugging Face and collaborate with Therna for further exploration capabilities.

For more information on how to utilize the Chronos study sets or to explore partnership opportunities, visit therna.com.